Aorta response to secretin in intact and diabetic rats

Polish Journal of Pharmacology

Volumn 53, Issue 6, 2001, Pages 647-651

  Wiśniewska, Róza J ^a   Sitniewska, Ewa M ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Diabetes; Isolated aorta; Rats; Secretin

Indexed keywords

GASTROINTESTINAL HORMONE; POTASSIUM CHLORIDE; SECRETIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY DILATATION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RESPONSE; ISOMETRICS; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; DIABETES MELLITUS, EXPERIMENTAL; ISOMETRIC CONTRACTION; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; SECRETIN;

EID: 0035693042     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The effect of secretin on peripheral arterial blood flow
2. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: Role of polyol pathway
3. Secretin and VIP-stimulated adenylate cyclase from rat heart. Impairment in spontaneous hypertension
4. Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation
5. Effect of secretin on pacemarker activity and contarcility in the isolated blood-perfused atrium of the dog
6. Species variations and physiopathology of VIP-PHI-secretin receptors in heart and lung
7. Impairement of endothelium-dependent relaxation in aortae from spontaneously diabetic rats
8. Effects of cholecystokinin (CCK-33) and its fragments, c-terminal octapeptide (CCK-8) and c-terminal tetrapeptide (CCK-4), on the circulatory system of diabetic rats
9. 2, but not noradrenaline, of aorta from rats with streptozotocin-induced diabetes mellitus
10. Thickened cerebral cortical capillary basement membranes in diabetes
11. Microvascular alterations develop in Syrian hamsters after the induction of diabetes mellitus by streptozotocin
12. - channels in bile duct epithelial cells through cAMP-dependent mechanism
13. 2, glucagon and secretin on the hepatic arterial vascular bed of the dog
14. Interaction of porcine vasoactive intestinal peptide with dispersed pancreatic acinar cells from the quinea pig. Structural requirements for effects of vasoactive intestinal peptide and secretin on cellular 3′5′-monophosphate
15. The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (FA/?) Zucker rats
16. Secretin-induced changes in rate, contractility and adenylate cyclase activity in rat heart atria
17. Cardiovascular effects of secretin
18. Cardiovascular effects of secretin in intact rats versus rats with streptozotocin-induced diabetes mellitus
19. Influence of nitric oxide on the cardiovascular action of secretin in intact rats. Part A. Does nitric oxide influence the effect of secretin on arterial blood pressure?
20. Influence of nitric oxide on the cardiovascular action of secretin in intact rats. Part B. Does nitric oxide influence the effect of secretin on isolated heart function?
21. Secretin stimulates cyclic AMP and inositol triphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms
22. Secretin and vasoactive intestinal peptide receptors: Members of a unique family of G protein-coupled receptors
23. Modulation of vascular tonus by endothelium in experimental diabetes
24. + and pepsin secretion and on urinary electrolyte excretion in man
25. Some statistical methods useful in circulation research